Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Ethical Issues in Schizophrenia: Considerations for Treatment and Research
1
x
$
30.00
View Cart
Checkout
Home
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
“Ethical Issues in Schizophrenia: Considerations for Treatment and Research” has been added to your cart.
View cart
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 2 Articles
Tags:
asenapine
,
clinical-trial
,
john-panagides
,
larry-alphs
,
md
,
ms
,
negative-symptoms
,
phd
,
schizophrenia
,
scott-lancaster
,
study-design
Description
Description
Larry Alphs, MD, PhD
ORIGINAL RESEARCH
Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
Larry Alphs, MD, PhD, John Panagides, PhD, and Scott Lancaster, MS
Related products
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Treatment with Olanzapine: Early Predictors of Weight Gain Risk
$
30.00
Add to cart
Details
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
$
30.00
Add to cart
Details
Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
$
30.00
Add to cart
Details
Page load link
Go to Top
